Ovarian stimulation in cancer patients

When performing ovarian stimulation for fertility preservation in cancer patients it is critical to understand time constraints, potential complications, risks, and the limited time opportunity.

Like Comment

Authors

Hakan Cakmak, M.D., Mitchell P. Rosen, M.D.

Volume 99, Issue 6, Pages 1476-1484, May 2013

Abstract

The patients referred for fertility preservation due to a malignant disease do not represent the typical population of subfertile patients treated in the in vitro fertilization units. Cancer may affect multiple tissues throughout the body and can result in variety of complications during controlled ovarian stimulation. Determination of the controlled ovarian stimulation protocol and gonadotropin dose for oocyte/embryo cryopreservation requires an individualized assessment. In this review, we highlight the new protocols that are emerging to reduce time constraints and emphasize management considerations to decrease complications.

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00445-7/fulltext


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.